Search Results - "Alsehli, Mosa H"

Development of Polyvinyl Alcohol/Kaolin Sponges Stimulated by Marjoram as Hemostatic, Antibacterial, and Antioxidant Dressings for Wound Healing Promotion by Tamer, Tamer M, Alsehli, Mosa H, Omer, Ahmed M, Afifi, Tarek H, Sabet, Maysa M, Mohy-Eldin, Mohamed S, Hassan, Mohamed A

“…The predominant impediments to cutaneous wound regeneration are hemorrhage and bacterial infections that lead to extensive inflammation with lethal impact. We…”
Get full text

Synthesis and Characterization of a New Class of Chromene-Azo Sulfonamide Hybrids as Promising Anticancer Candidates with the Exploration of Their EGFR, hCAII, and MMP-2 Inhibitors Based on Molecular Docking Assays by Alblewi, Fawzia F., Alsehli, Mosa H., Hritani, Zainab M., Eskandrani, Areej, Alsaedi, Wael H., Alawad, Majed O., Elhenawy, Ahmed A., Ahmed, Hanaa Y., El-Gaby, Mohamed S. A., Afifi, Tarek H., Okasha, Rawda M.

“…In this study, novel selective antitumor compounds were synthesized based on their fundamental pharmacophoric prerequisites associated with EGFR inhibitors. A…”
Get full text

DFT and In-silico Investigations, along with In-vitro Antitumor and Antimicrobial Assessments of Pharmacological Molecules by Alsehli, Mosa H, Seth, Daya S, El-Gaby, Mohamed S A, Okasha, Rawda M, Hagar, Mohamed, Afifi, Tarek H, Naqvi, Arshi

“…Molecules bearing an active methylene bridge are one of the most fruitful and remarkable precursors that have been incorporated into the synthetic strategy of…”
Get more information

Synthesis, Cytotoxic Activity, Crystal Structure, DFT, Molecular Docking Study of β-Enaminonitrile Incorporating 1H-Benzo[f]Chromene Moiety by Alsehli, Mosa H., Al-Harbi, Lali M., Okasha, Rawda M., Fouda, Ahmed M., Ghabbour, Hazem A., Amr, Abd El-Galil E., Elhenawy, Ahmed A., El-Agrody, Ahmed M.

“…In this work, we used microwave irradiation conditions to synthesize β-enaminonitrile (4), which was affirmed using single crystal X-ray diffraction and the…”
Get full text

Synthesis, crystal structure, DFT studies, molecular docking, of 2-amino-6-methoxy-4-(4-nitrophenyl)-4H-benzo[h]chromene-3-carbonitrile as tyrosinase inhibitor by Al-Dies, Al-Anood M., El-Wahab, Ashraf H. F. Abd, Alamri, Abdullah Ali, Borik, Rita M.A., Mohamed, Hany M., Assirey, Eman A., Alsehli, Mosa H., Moussa, Ziad, Alzamly, Ahmed, Mehany, Ahmed B.M., Elhenawy, Ahmed A., El-Agrody, Ahmed M.

“…•β-Enaminonitrile (4): Synthesis using ultrasonic irradiation, then confirmed by single crystal X-ray diffraction and multi-nuclear NMR spectroscopy.•The 3D…”
Get full text

Chitosan-Porphyrin Nanocomposite Films: Preparation, Characterization, and Optical Properties by Aljuhani, Ateyatallah, Khalil, Khaled D., Alsehli, Mosa H., Bashal, Ali H., Zaki, Ayman A.

“…In this study, porphyrin was prepared and doped with chitosan biopolymer using the solution casting process at various weight percentages (5 and 10 wt% CS-PP)…”
Get full text

Synthesis and Characterization of a New Class of Chromene-Azo Sulfonamide Hybrids as Promising Anticancer Candidates with the Exploration of Their EGFR, Ih/ICAII, and MMP-2 Inhibitors Based on Molecular Docking Assays by Alblewi, Fawzia F, Alsehli, Mosa H, Hritani, Zainab M, Eskandrani, Areej, Alsaedi, Wael H, Alawad, Majed O, Elhenawy, Ahmed A, Ahmed, Hanaa Y, El-Gaby, Mohamed S. A, Afifi, Tarek H, Okasha, Rawda M

“…In this study, novel selective antitumor compounds were synthesized based on their fundamental pharmacophoric prerequisites associated with EGFR inhibitors. A…”
Get full text

Synthesis and Characterization of a New Class of Chromene-Azo Sulfonamide Hybrids as Promising Anticancer Candidates with the Exploration of Their EGFR, h CAII, and MMP-2 Inhibitors Based on Molecular Docking Assays by Alblewi, Fawzia F, Alsehli, Mosa H, Hritani, Zainab M, Eskandrani, Areej, Alsaedi, Wael H, Alawad, Majed O, Elhenawy, Ahmed A, Ahmed, Hanaa Y, El-Gaby, Mohamed S A, Afifi, Tarek H, Okasha, Rawda M

“…In this study, novel selective antitumor compounds were synthesized based on their fundamental pharmacophoric prerequisites associated with EGFR inhibitors. A…”
Get full text